MESS (first-seizure recurrence risk)

MESS (first-seizure recurrence risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

Open the MESS (first-seizure recurrence risk) → Runs in your browser. No signup, no tracking.

What this is

MESS (first-seizure recurrence risk) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. MESS (first-seizure recurrence risk) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

When to use it

Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.

References

Kim LG, Johnson TL, Marson AG, Chadwick DW; MRC MESS Study Group. Prediction of risk of seizure recurrence after a single seizure and early epilepsy. Lancet Neurol. 2006;5(4):317-322. Read the source ↗

Worked example: MESS high risk (score 2/4): more than 50% recurrence within 3-5 years even with immediate treatment, and about 65% at 5 years if treatment is deferred.

Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.

Built by Clay Good. Source on GitHub.